Treatment of hemiplegic migraine with Anti-CGRP monoclonal antibodies: a retrospective study
Not Applicable
- Conditions
- Hemiplegic migraine
- Registration Number
- JPRN-UMIN000048097
- Lead Sponsor
- Tominaga Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Treatment duration is less than 3 months No motor symptoms at baseline
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes from baseline in monthly headache days
- Secondary Outcome Measures
Name Time Method